| scholarly article | Q13442814 |
| P2093 | author name string | Howard A Reber | |
| Oscar J Hines | |||
| Joseph Kim | |||
| Dave S B Hoon | |||
| Anton J Bilchik | |||
| Naoyuki Umetani | |||
| Suzanne Hiramatsu | |||
| P2860 | cites work | Initial sequencing and analysis of the human genome | Q21045365 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | patient | Q181600 |
| periampullary cancer | Q260688 | ||
| P304 | page(s) | 1062-1069 | |
| P577 | publication date | 2006-06-01 | |
| P1433 | published in | Clinical Chemistry | Q849687 |
| P1476 | title | Increased integrity of free circulating DNA in sera of patients with colorectal or periampullary cancer: direct quantitative PCR for ALU repeats | |
| P478 | volume | 52 |
| Q35740150 | A direct plasma assay of circulating microRNA-210 of hypoxia can identify early systemic metastasis recurrence in melanoma patients |
| Q38704258 | A headlight on liquid biopsies: a challenging tool for breast cancer management. |
| Q35962455 | AIM1 and LINE-1 epigenetic aberrations in tumor and serum relate to melanoma progression and disease outcome |
| Q33560085 | Abnormal DNA methylation as a cell-free circulating DNA biomarker for colorectal cancer detection: A review of literature |
| Q90620153 | An enzymatic on/off switch-mediated assay for KRAS hotspot point mutation detection of circulating tumor DNA |
| Q55333277 | Analysis of the concentrations and size distributions of cell-free DNA in schizophrenia using fluorescence correlation spectroscopy. |
| Q57170570 | Assessing the Impact of Circulating Tumor DNA (ctDNA) in Patients With Colorectal Cancer: Separating Fact From Fiction |
| Q90716516 | Assessing the practice of LuPOR for poor responders: a prospective study evaluating follicular fluid cfDNA levels during natural IVF cycles |
| Q33841321 | Assessment of the circulating cell-free DNA marker association with diagnosis and prognostic prediction in patients with lymphoma: a single-center experience |
| Q38699032 | Blood circulating tumor DNA for non-invasive genotyping of colon cancer patients |
| Q52571244 | Blood free-circulating DNA testing by highly sensitive methylation assay to diagnose colorectal neoplasias. |
| Q92590013 | Cell-free DNA donor fraction analysis in pediatric and adult heart transplant patients by multiplexed allele-specific quantitative PCR: Validation of a rapid and highly sensitive clinical test for stratification of rejection probability |
| Q35750317 | Cell-free DNA in Human Follicular Microenvironment: New Prognostic Biomarker to Predict in vitro Fertilization Outcomes |
| Q26750899 | Cell-free circulating tumor DNA in cancer |
| Q34184393 | Cell-free nucleic acids as biomarkers in cancer patients |
| Q45323416 | Cell-free plasma DNA as biochemical biomarker for the diagnosis and follow-up of prostate cancer patients |
| Q43512551 | Characterization of cell-free circulating DNA in plasma in patients with prostate cancer. |
| Q58114470 | Circulating Cell-Free DNA and Colorectal Cancer: A Systematic Review |
| Q36247593 | Circulating Cell-Free DNA in Dogs with Mammary Tumors: Short and Long Fragments and Integrity Index |
| Q48180449 | Circulating DNA of HOTAIR in serum is a novel biomarker for breast cancer |
| Q38191574 | Circulating and stool nucleic acid analysis for colorectal cancer diagnosis. |
| Q55031209 | Circulating cell free DNA as the diagnostic marker for colorectal cancer: a systematic review and meta-analysis. |
| Q35748716 | Circulating cell-free DNA and its integrity as a prognostic marker for breast cancer |
| Q34354622 | Circulating cell-free DNA in serum as a biomarker for diagnosis and prognostic prediction of colorectal cancer |
| Q45799429 | Circulating cell-free DNA in serum as a biomarker of colorectal cancer. |
| Q54409514 | Circulating mitochondrial DNA in serum: a universal diagnostic biomarker for patients with urological malignancies. |
| Q37690454 | Circulating nucleic acids in cancer and pregnancy |
| Q37014663 | Circulating nucleic acids in plasma and serum (CNAPS): applications in oncology |
| Q36117667 | Circulating nucleic acids in plasma and serum: diagnosis and prognosis in cancer |
| Q37593852 | Circulating nucleic acids: An analysis of their occurrence in malignancies. |
| Q35125657 | Circulating tumour markers can define patients with normal colons, benign polyps, and cancers |
| Q90216774 | Clinical Applications of Cerebrospinal Fluid Circulating Tumor DNA as a Liquid Biopsy for Central Nervous System Tumors |
| Q27003134 | Colorectal Cancer Biomarkers: Where Are We Now? |
| Q46578913 | Colorectal Cancer Blood-Based Biomarkers. |
| Q30238915 | Colorectal Carcinoma: A General Overview and Future Perspectives in Colorectal Cancer |
| Q35477655 | Correlation between plasma DNA and tumor status in an animal model |
| Q33293788 | DNA degradation test predicts success in whole-genome amplification from diverse clinical samples |
| Q27336155 | DNA hybridization detection with 100 zM sensitivity using piezoelectric plate sensors with an improved noise-reduction algorithm. |
| Q37215564 | DNA integrity as biomarker in pancreatic cyst fluid |
| Q33549268 | Decoding circulating nucleic acids in human serum using microfluidic single molecule spectroscopy |
| Q35952500 | Decreased serum cell-free DNA levels in rheumatoid arthritis. |
| Q49625940 | Diagnostic Value of Circulating Free DNA Integrity and Global Methylation Status in Gall Bladder Carcinoma |
| Q52944557 | Diagnostic and prognostic role of cell-free DNA testing for colorectal cancer patients. |
| Q38152782 | Diagnostic and prognostic value of circulating tumor-related DNA in cancer patients. |
| Q44158160 | Diagnostic relevance of plasma DNA and DNA integrity for breast cancer |
| Q35111355 | Direct quantification of cell-free, circulating DNA from unpurified plasma |
| Q35543094 | Do circulating tumor cells, exosomes, and circulating tumor nucleic acids have clinical utility? A report of the association for molecular pathology |
| Q37141998 | Early detection of colon cancer: new tests on the horizon |
| Q41785348 | Effect of DNase and antibiotics on biofilm characteristics |
| Q26778026 | Emerging blood-based biomarkers for detection of gastric cancer |
| Q42546251 | Epigenetic alteration: new insights moving from tissue to plasma - the example of PCDH10 promoter methylation in colorectal cancer. |
| Q37385238 | Epigenetic status of LINE-1 predicts clinical outcome in early-stage rectal cancer. |
| Q34322575 | Establishment of tumor-specific copy number alterations from plasma DNA of patients with cancer. |
| Q48253205 | Evaluation of Streck BCT and PAXgene Stabilised Blood Collection Tubes for Cell-Free Circulating DNA Studies in Plasma. |
| Q43244656 | Fragmentation of DNA affects the accuracy of the DNA quantitation by the commonly used methods. |
| Q36246087 | Generating Exome Enriched Sequencing Libraries from Formalin-Fixed, Paraffin-Embedded Tissue DNA for Next-Generation Sequencing |
| Q37764795 | Generation, function, and prognostic utility of somatic mitochondrial DNA mutations in cancer |
| Q42378966 | Highly sensitive and specific Alu-based quantification of human cells among rodent cells |
| Q58645659 | Implementing a strategy for on-chip detection of cell-free DNA fragments using GMR sensors: A translational application in cancer diagnostics using ALU elements |
| Q85012315 | Increased integrity of circulating cell-free DNA in plasma of patients with acute leukemia |
| Q41181289 | Integrity and Quantity of Total Cell-Free DNA in the Diagnosis of Thyroid Cancer: Correlation with Cytological Classification |
| Q35212779 | Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients |
| Q38700529 | Liquid biopsy utility for the surveillance of cutaneous malignant melanoma patients |
| Q47143655 | Methylation of 14-3-3σ gene and prognostic significance of 14-3-3σ expression in non-small cell lung cancer |
| Q34499759 | Multiparametric analysis of cell-free DNA in melanoma patients |
| Q26796348 | New findings on primary and acquired resistance to anti-EGFR therapy in metastatic colorectal cancer: do all roads lead to RAS? |
| Q37307603 | Noninvasive detection of EGFR T790M in gefitinib or erlotinib resistant non-small cell lung cancer |
| Q38993983 | Plasma DNA integrity as a biomarker for primary and metastatic breast cancer and potential marker for early diagnosis |
| Q33395491 | Plasma circulating nucleic acids levels increase according to the morbidity of Plasmodium vivax malaria |
| Q34421199 | Pleural fluid cell-free DNA integrity index to identify cytologically negative malignant pleural effusions including mesotheliomas |
| Q64108223 | Polyethylene glycol improves current methods for circulating extracellular vesicle-derived DNA isolation |
| Q35113393 | Potential of soluble CD26 as a serum marker for colorectal cancer detection. |
| Q36219131 | Prediction of cancer progression in a group of 73 gastric cancer patients by circulating cell-free DNA. |
| Q35016114 | Prediction of clear cell renal cell carcinoma by integrity of cell-free DNA in serum |
| Q37544605 | Prediction of the efficacy of immunotherapy by measuring the integrity of cell-free DNA in plasma in colorectal cancer |
| Q37960201 | Prognostic and predictive roles for circulating biomarkers in gastrointestinal cancer |
| Q48923805 | Prognostic value of free DNA quantification in serum and cerebrospinal fluid in glioma patients |
| Q55339588 | Prognostic value of the DNA integrity index in patients with malignant lung tumors. |
| Q50155659 | Quantification of Circulating Free DNA as a Diagnostic Marker in Gall Bladder Cancer. |
| Q26861681 | Recent advances in clinical applications of circulating cell-free DNA integrity |
| Q92421741 | Recurrent Genetic Abnormalities in Human Pluripotent Stem Cells: Definition and Routine Detection in Culture Supernatant by Targeted Droplet Digital PCR |
| Q59233182 | Role of quantitative and qualitative characteristics of free circulating DNA in the management of patients with non-small cell lung cancer |
| Q46913168 | Salivary DNA and markers of oxidative stress in patients with chronic periodontitis |
| Q49216736 | Serum DNA integrity index as a potential molecular biomarker in endometrial cancer |
| Q55439402 | Serum circulating cell free DNA as potential diagnostic and prognostic biomarker in non small cell lung cancer. |
| Q37902210 | Serum tests for colorectal cancer screening |
| Q47248140 | Size distribution of circulating cell-free DNA in sera of breast cancer patients in the course of adjuvant chemotherapy |
| Q37015727 | The Prognostic Value of Circulating Cell-Free DNA in Colorectal Cancer: A Meta-Analysis |
| Q39068458 | The clinical role of circulating free tumor DNA in gastrointestinal malignancy |
| Q37225239 | The clinical utilization of circulating cell free DNA (CCFDNA) in blood of cancer patients |
| Q64078507 | The emerging role of cell-free DNA as a molecular marker for cancer management |
| Q37599158 | The role of cell-free circulating DNA in the diagnosis and prognosis of prostate cancer |
| Q92378915 | Tumour biomarkers-Tracing the molecular function and clinical implication |
| Q50085730 | Use of free circulating DNA for diagnosis, prognosis and treatment of cancer |
| Q37098291 | Utility of KRAS mutation detection using circulating cell-free DNA from patients with colorectal cancer |
| Q54175476 | Validation of a quantitative polymerase chain reaction method for human Alu gene detection in microchimeric pigs used as donors for xenotransplantation. |
Search more.